Literature DB >> 26856697

IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.

Shoichi Iida1, Hidetoshi Tsuda2, Toshiaki Tanaka3, Danielle D Kish3, Toyofumi Abe2, Charles A Su4, Ryo Abe5, Kazunari Tanabe5, Anna Valujskikh3, William M Baldwin4, Robert L Fairchild6.   

Abstract

Reperfusion of organ allografts induces a potent inflammatory response that directs rapid memory T cell, neutrophil, and macrophage graft infiltration and their activation to express functions mediating graft tissue injury. The role of cardiac allograft IL-1 receptor (IL-1R) signaling in this early inflammation and the downstream primary alloimmune response was investigated. When compared with complete MHC-mismatched wild-type cardiac allografts, IL-1R(-/-) allografts had marked decreases in endogenous memory CD8 T cell and neutrophil infiltration and expression of proinflammatory mediators at early times after transplant, whereas endogenous memory CD4 T cell and macrophage infiltration was not decreased. IL-1R(-/-) allograft recipients also had marked decreases in de novo donor-reactive CD8, but not CD4, T cell development to IFN-γ-producing cells. CD8 T cell-mediated rejection of IL-1R(-/-) cardiac allografts took 3 wk longer than wild-type allografts. Cardiac allografts from reciprocal bone marrow reconstituted IL-1R(-/-)/wild-type chimeric donors indicated that IL-1R signaling on graft nonhematopoietic-derived, but not bone marrow-derived, cells is required for the potent donor-reactive memory and primary CD8 T cell alloimmune responses observed in response to wild-type allografts. These studies implicate IL-1R-mediated signals by allograft parenchymal cells in generating the stimuli-provoking development and elicitation of optimal alloimmune responses to the grafts.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26856697      PMCID: PMC4779689          DOI: 10.4049/jimmunol.1500876

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Anakinra potentiates the protective effects of etanercept in transplantation of marginal mass human islets in immunodeficient mice.

Authors:  M McCall; R Pawlick; T Kin; A M J Shapiro
Journal:  Am J Transplant       Date:  2011-11-04       Impact factor: 8.086

2.  Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance.

Authors:  X Zhao; O Boenisch; M Yeung; B Mfarrej; Sunmi Yang; L A Turka; M H Sayegh; J Iacomini; X Yuan
Journal:  Am J Transplant       Date:  2011-10-12       Impact factor: 8.086

Review 3.  Rejection of the kidney allograft.

Authors:  Brian J Nankivell; Stephen I Alexander
Journal:  N Engl J Med       Date:  2010-10-07       Impact factor: 91.245

Review 4.  Ischemia and reperfusion--from mechanism to translation.

Authors:  Holger K Eltzschig; Tobias Eckle
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

5.  The Registry of the International Society for Heart and Lung Transplantation: 29th official adult heart transplant report--2012.

Authors:  Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Anne I Dipchand; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz
Journal:  J Heart Lung Transplant       Date:  2012-10       Impact factor: 10.247

Review 6.  Overcoming the memory barrier in tolerance induction: molecular mimicry and functional heterogeneity among pathogen-specific T-cell populations.

Authors:  Mandy L Ford; Christian P Larsen
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

7.  Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance.

Authors:  Daniel Kreisel; Seiichiro Sugimoto; Jihong Zhu; Ruben Nava; Wenjun Li; Mikio Okazaki; Sumiharu Yamamoto; Mohsen Ibrahim; Howard J Huang; Kelsey A Toth; Jon H Ritter; Alexander S Krupnick; Mark J Miller; Andrew E Gelman
Journal:  Blood       Date:  2011-10-04       Impact factor: 22.113

8.  A TLR5 agonist inhibits acute renal ischemic failure.

Authors:  Nobuyuki Fukuzawa; Marianne Petro; William M Baldwin; Andrei V Gudkov; Robert L Fairchild
Journal:  J Immunol       Date:  2011-09-02       Impact factor: 5.422

9.  Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms.

Authors:  Wentao Liu; Xiang Xiao; Gulcin Demirci; Joren Madsen; Xian C Li
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

Review 10.  An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases.

Authors:  Nader Pazyar; Amir Feily; Reza Yaghoobi
Journal:  Curr Clin Pharmacol       Date:  2012-11
View more
  3 in total

1.  IL-1RA regulates immunopathogenesis during fungal-associated allergic airway inflammation.

Authors:  Matthew S Godwin; Kristen M Reeder; Jaleesa M Garth; Jonathan P Blackburn; MaryJane Jones; Zhihong Yu; Sadis Matalon; Annette T Hastie; Deborah A Meyers; Chad Steele
Journal:  JCI Insight       Date:  2019-11-01

Review 2.  Inflammasomes and IL-1 biology in the pathogenesis of allograft dysfunction.

Authors:  S Samuel Weigt; Vyacheslav Palchevskiy; John A Belperio
Journal:  J Clin Invest       Date:  2017-06-01       Impact factor: 14.808

3.  B cell-derived IL-1β and IL-6 drive T cell reconstitution following lymphoablation.

Authors:  Suheyla Hasgur; Ran Fan; Daniel B Zwick; Robert L Fairchild; Anna Valujskikh
Journal:  Am J Transplant       Date:  2020-05-16       Impact factor: 8.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.